This study investigated the effects of Galileo Therapy in Spinal Muscle Atrophy (SMA, type II, III, IIIa, age 2-7) (Cologne Concept: 3x3 minutes, 10 session/week, 26 weeks). Galileo Therapy showed significant improvements in muscle function in Gross Motor Function Test (GMFM-66, +4%) and Hammersmith Functional Mobility Scale (HFMS, +9,5%). The following 6 months of standard therapy did not show further significant improvements...
Galileo Research Facts No. 157: Can Galileo Therapy improve muscle function and gait speed in children with Ataxia?
This study shows the effect of Galileo Therapy (Cologne Concept: 3x3 minutes, 10 session/week, 26 weeks) in Ataxia patients (3-14 years, 2 groups: progressive and non-progressive). Both Galileo groups show significant improvements in GRMF66 (+7%), gait speed (+12%), 1MWT (+41%). In the following 6 months with standard therapy there was no additional relevant improvement in the parameters...
Galileo Research Facts No. 124: Can Galileo Therapy improve muscle force and endurance in COPD-patients?
This study investigated the effects of Galileo Therapy in COPD patients. (6-24Hz, 3*3 min., progressive, 150° squat, pos.2-3, 2/week, 3 months, +15 min. warmup+cool-down). The control group received Calisthenics exercises (2*30 min./week). While the control group did not show any significant changes that Galileo group showed highly significant improvements in muscle force and endurance with up to +38% (leg press, 1RM)...
Galileo Research Facts No. 122: Can Galileo Therapy improve muscle function and muscle mass in OI patients?
This study documented the effects of Galileo Training in children with OI (Osteogenesis Imperfecta) during the Cologne therapy concept “auf die Beine” on muscle function and muscle mass (10-20Hz, patient individual exercises, 10*15min./week, 6 months + 6 months follow-up). The results showed a significant growth corrected increase of muscle mass (+7%), an significant increase of leg force (+7%) and of the GMFM66 (+9%)...